Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antihypertensive therapy in the nineties].

P Weidmann1, P Ferrari

  • 1Medizinische Universitäts-Poliklinik, Inselspital, Bern.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|February 11, 1992
PubMed
Summary

Managing hypertension is crucial for cardiovascular health. Newer drugs and lifestyle changes improve outcomes by addressing multiple risk factors, not just blood pressure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MCNPX internal dosimetry studies based on the NORMAN-05 voxel model.

Radiation protection dosimetry·2007
Same author

Monte Carlo evaluated parameters for internal dosimetry.

Radiation protection dosimetry·2007
Same author

Acid reflux into the oesophagus does not influence exercise-induced airway narrowing in bronchial asthma.

British journal of sports medicine·2007
Same author

Ouabain-dependent signaling in caveolae as a novel therapeutic target for hypertension.

Cellular and molecular biology (Noisy-le-Grand, France)·2007
Same author

Preliminary studies on neutron conversion coefficients calculated with MCNPX in NORMAN voxel phantom.

Radiation protection dosimetry·2007
Same author

Dementia and occupational therapy.

Archives of gerontology and geriatrics·2007

Area of Science:

  • Cardiology and Hypertension Research
  • Pharmacology and Therapeutics
  • Public Health and Preventive Medicine

Context:

  • Elevated blood pressure (BP) significantly increases cardiovascular complication risk.
  • Hypertension often coexists with other cardiovascular risk factors like metabolic derangements and dyslipidemia.
  • Conventional treatments show limitations in reducing specific cardiovascular events like coronary heart disease.

Purpose:

  • To review current understanding of hypertension management.
  • To evaluate the role of various antihypertensive drug classes.
  • To emphasize a comprehensive approach including non-pharmacologic measures and addressing associated risk factors.

Summary:

  • Borderline and established hypertension necessitate treatment to improve patient survival.
  • Newer antihypertensive agents (ACE-inhibitors, calcium antagonists, alpha-blockers) show promise in reducing left ventricular hypertrophy and are metabolically neutral.
  • Non-pharmacologic interventions are foundational, with medication choices tailored to individual patient profiles and comorbidities.

Impact:

  • Highlights the need for treatment strategies that address multiple cardiovascular risk factors beyond just lowering BP.
  • Suggests newer drug classes may offer advantages over conventional therapies for specific outcomes.
  • Underscores the importance of personalized medicine in hypertension management for improved long-term survival and reduced morbidity.

Related Experiment Videos